Table 3 Demographic data and clinical characteristics of patients with critical COVID-19
From: Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19
Variable | Critical COVID-19 with ILD (n = 27) | Critical COVID-19 (n = 72) | P-value |
|---|---|---|---|
Age (years), IQR | 62 (55–69) | 65 (60–71) | 0.3 |
Gender (Women), (%) | 17 (63) | 22 (31) | 0.003 |
BMI (kg/m2), IQR | 27 (25–29) | 29 (25–32) | 0.4 |
Type 2 diabetes, (%) | 6 (22) | 19 (26) | 0.4 |
Systemic high blood pressure (%) | 8 (30) | 28 (39) | 0.2 |
Complete vaccination (%) | 5 (19) | 6 (8) | 0.1 |
Oxygen saturation (%) IQR | 70 (61–82) | 64 (52–78) | 0.2 |
Days of evolution (#) IQR | 11 (7–16) | 10 (7–13) | 0.7 |
Leukocytes absolute number (10^3/mm3), IQR | 10 (7–13) | 12 (8–14) | 0.1 |
Neutrophiles absolute number (10^3/mm3), IQR | 9 (6–12) | 10 (6–13) | 0.3 |
Lymphocytes absolute number (10^3/mm3), IQR | 0.7 (0.3–1) | 0.8 (0.5–1) | 0.07 |
CRP (mg/dL), IQR | 18 (11–24) | 19 (11–26) | 0.5 |
Procalcitonin (ng/mL), IQR | 0.8 (0.07–0.6) | 0.6 (0.1–0.6) | 0.6 |
Ferritin (ng/mL), IQR | 1325 (449–1693) | 1628 (669–2190) | 0.2 |
Fibrinogen (mg/dL), IQR | 705 (677–779) | 713 (624–776) | 0.7 |
D-Dimer (μg/dL), IQR | 5 (0.8–4.8) | 4.1 (0.7–3.5) | 0.3 |
Dead (%) | 17 (63) | 24 (33) | 0.007 |